Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
BMC Developmental Biology|April 10, 2009
Adenomatous polyposis coli-mediated control of beta-catenin is essential for both chondrogenic and osteogenic differentiation of skeletal precursorsRazvan L Miclea, Marcel Karperien, Cathy Aj Bosch, et al.
Endocrine-Related Cancer|October 21, 2015
Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancerJan Kroon, Martin Puhr, Jeroen T Buijs, et al.
Cancer Research|June 3, 2010
High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancerChristel van den Hoogen, Geertje van der Horst, Henry Cheung, et al.
Molecular Therapy. Oncology|February 3, 2026
Improved oncolytic and immunostimulatory activity of the spontaneous <i>jin-3</i> reovirus mutant in preclinical bladder cancer modelsArjanneke F van de Merbel, Maaike H van der Mark, Lobke C M Hensen, et al.
International Journal of Molecular Sciences|February 11, 2021
The Identification of Small Molecule Inhibitors That Reduce Invasion and Metastasis of Aggressive CancersArjanneke F van de Merbel, Onno van Hooij, Geertje van der Horst, et al.
Molecular Oncology|September 8, 2020
Cationic amphiphilic drugs as potential anticancer therapy for bladder cancerGeertje van der Horst, Arjanneke F van de Merbel, Eline Ruigrok, et al.
The American Journal of Pathology|August 29, 2007
BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivoJeroen T Buijs, Cyrill A Rentsch, Geertje van der Horst, et al.
European Journal of Cancer (Oxford, England : 1990)|February 9, 2021
A multimodal molecular imaging approach targeting urokinase plasminogen activator receptor for the diagnosis, resection and surveillance of urothelial cell carcinomaVictor M Baart, Geertje van der Horst, Marion M Deken, et al.
Cancer Research|September 19, 2007
Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancerJeroen T Buijs, Nico V Henriquez, Petra G M van Overveld, et al.
Cancer Immunology Research|May 19, 2025
TCR-based therapy directed against kallikrein-related peptidase 4 is safe and effective against prostate cancerRosa A van Amerongen, Sander Tuit, Dennis F G Remst, et al.
Pageof 5